Clinical Trials - Diabetes
Short Study Name |
Protocol Title |
Principal Investigator |
Site(s) |
| Diabetes/ACS | A multicenter, randomized, double-blind, placebo-controlled study to evaluate cardiovascular outcomes following treatment with Alogliptin in addition to standard of care in subjects with Type 2 Diabetes and Acute Coronary Syndrome | Saleem Aman, MD |
Wheaton Franciscan Healthcare - St. Francis Wheaton Franciscan Healthcare - Franklin |
For information on enrolling in clinical trials, please call or email:
Kelli Holton, Regulatory Affairs Assistant
(414) 874-4541